Skip Navigation Menu
Government of Ontario Central Web Site Ontario Ministry of Health and Long-Term Care
Return to Home Page Government of Ontario Central Web Site Contact us for questions and comments Site map Version française de cette site web
Information Channels Public Information Health Care Providers News Media Text Only Version
Index Health Care Provider Section
Formulary Downloads
O P D P   H O M E
Plan to Reform Ontario's Drug System
Legislation
Formulary
· About the Formulary
· Formulary Edition 40 and 41
  Downloads

· Search e-Formulary
· Formulary Resources
· Drug Benefit Prices
  for products reimbursed
  under the EAP

· Conditions for Payment
  of Dispensing Fee

  – Exempted Products List
Exceptional Access Program
Publicly Funded Drug Programs
Executive Officer Communications
Drug Submissions
Patient Evidence Submission
How Drugs Are Approved
Councils
Drug Innovation Fund
MedsCheck
Glossary
Forms/Guidelines
FAQs
Resources
Contact Us

Formulary

Exceptional Access Program (EAP)

The Individual Clinical Review process is being phased out and a more streamlined Exceptional Access Program (EAP) has been created to handle requests for drugs that are not listed in the Formulary. For more information please visit the EAP section.

Drug Benefit Prices (DBPs) for products reimbursed under the EAP

Pursuant to section 15 of O.Reg. 201/96 made under the Ontario Drug Benefit Act (ODBA), the Executive Officer (EO) has entered into agreements with manufacturers to establish Drug Benefit Prices (DBPs) for products reimbursed under the Exceptional Access Program (EAP).

For the following products reimbursed under the EAP, the Health Network System (HNS) will adjudicate claims at the DBP listed below.

DIN Trade Name Strength Dosage Form DBP
Effective Date : January 19, 2012
02284227 Nexavar 200mg Tablet $46.0088
Effective Date : January 4, 2012
02215136 Saizen 3.3mg Vial $144.9000
02237971 Saizen 5mg Vial $217.5200
02272083 Saizen ClickEasy 5.83mg/mL 8.8mg Vial $348.0300
02350122 Saizen 5.83mg/mL 6mg/cartridge $261.0000
02350130 Saizen 8mg/mL 12mg/cartridge $522.0000
02350149 Saizen 8mg/mL 20mg/cartridge $870.0000
Effective date: December 28, 2011
02260565 Xolair 150mg Powder for solution injection sc (5mL vial) $600.0000
Effective date : December 5, 2011
02293129 Sprycel 20mg Oral tablet $35.7500
02293137 Sprycel 50mg Oral tablet $71.9500
02293145 Sprycel 70mg Oral tablet $78.9000
Effective date : November 14, 2011
02326442 Tykerb 250mg Tablet $23.5000
Effective date : November 7, 2011
02269201 Avonex PS 30mcg/0.5mL Prefilled syringe $399.0250
09857395 Avonex Pen 30mcg/0.5mL Prefilled autoinjector pen $399.0250
Effective date : October 28, 2011
02370816 Victrelis 200mg Cap $12.5000
02371448 Victrelis Triple 200mg Cap &
200mg Cap &
80mcg Inj Pd
168 Caps &
56 Caps &
2 Redipens, Combination Kit
$2,652.5500
02371456 Victrelis Triple 200mg Cap &
200mg Cap &
100mcg Inj Pd
168 Caps &
56 Caps &
2 Redipens, Combination Kit
$2,652.5500
02371464 Victrelis Triple 200mg Cap &
200mg Cap &
120mcg Inj Pd
168 Caps &
70 Caps &
2 Redipens, Combination Kit
2,726.0000
02371472 Victrelis Triple 200mg Cap &
200mg Cap &
150mcg Inj Pd
168 Caps &
84 Caps &
2 Redipens, Combination Kit
$2,726.0000
09857396 Victrelis Triple 200mg Cap &
200mg Cap &
150mcg Inj Pd
168 Caps & 98 Caps &
2 Redipens, Combination Kit
$2,726.0000
Effective date : October 27, 2011
02357119 Vpriv ® 400U Vial $1955.0000
Effective date : October 26, 2011
09857394 Enbrel Sureclick® 50mg/mL Prefilled autoinjection $368.9075
Effective date : October 19, 2011
02287145 Fosrenol® 250mg Chewable tab $1.0527
02287153 Fosrenol® 500mg Chewable tab $2.1053
02287161 Fosrenol® 750mg Chewable tab $3.1682
02287188 Fosrenol® 1000mg Chewable tab $4.2004
Effective date : October 11, 2011
02299909 Cubicin 500mg/10mL Vial powder for injection $174.0000
Effective date : September 16, 2011
02248676 Iressa 250mg Tablet $73.3000
Effective date : September 8, 2011
02349124 Effient 10mg Tablet (supplied as blister pack of 30 tablets) $2.6600
Effective date : September 12, 2011
02318253 Rebif 66ug Multi-Dose Cartridge $363.6300
02318261 Rebif 132ug Multi-Dose Cartridge $442.6800
02237319 Rebif 22mcg Pre-Filled Syringe $121.2100
02237320 Rebif 44mcg Pre-Filled Syringe $147.5600
Effective date : August 18, 2011
01968017 Neupogen 300mcg/mL 1mL vial injection $184.4600
09853464 Neupogen 480mcg/1.6mL injection $295.1360
Effective date : August 17, 2011
02357615 Vimpat 50mg F.C. Tablet $2.3200
02357623 Vimpat 100mg F.C. Tablet $3.3200
02357631 Vimpat 150mg F.C. Tablet $4.3200
02357658 Vimpat 200mg F.C. Tablet $5.3200
Effective date : July 22, 2011
02322285 Soliris 10mg/mL 30mL vial for IV injection $6,742.5000
Effective date : May 31, 2011
02280795 Sutent 12.5mg Cap $63.1525
02280809 Sutent 25mg Cap $126.3043
02280817 Sutent 50mg Cap $252.6089
Effective date : May 20, 2011
02350092 Actemra 20mg/mL Concentrate sol for infusion, 80mg/4mL vial $179.2000
02350106 Actemra 20mg/mL Concentrate sol for infusion, 200mg/10mL vial $448.0000
02350114 Actemra 20mg/mL Concentrate sol for infusion, 400mg/20mL vial $896.0000
Effective date: May 19, 2011
2282097 Orencia 250mg/15mL Vial $454.6000
02242572 Actos 15mg Tab $2.3783
02242573 Actos 30mg Tab $3.3319
02242574 Actos 45mg Tab $5.0099
02258595 Humira 40mg/0.8mL Pre-Filled Syr $715.1200
09857294 Humira 40mg/0.8mL Pre-Filled Pen $715.1200
02287420 Exjade 125mg Tab for Susp $10.2039
02287439 Exjade 250mg Tab for Susp $20.4075
02287447 Exjade 500mg Tab for Susp $40.8154
02286386 Tysabri 300mg/15mL Vial $2,986.0300
Effective date : May 18, 2011
02322854 Nplate 250mcg/0.5mL Powder for solution for injection $897.5000
02322862 Nplate 500mcg/1mL Powder for solution for injection $1795.0100
Effective date: February 11, 2011
02339528 Afinitor 10mg Tab $186.0000
02337819 Extavia 0.3mg/vial Powder for sc injection $99.3593
Effective date: February 4, 2011
02315874 Tasigna 200mg Cap $38.7147
Effective date: January 31, 2011
02338327 Adcirca 20mg Tab $13.0725
Effective date: December 24, 2010
02295709 Suboxone 8mg/2mg Tab $4.7300
Effective date : November 21, 2010
02245619 Copaxone 20mg/mL Pre-Filled Syringe $43.2000
Effective date : October 18, 2010
02324784 Simponi 50mg/0.5mL Auto-Injector $1447.0000
02324776 Simponi 50mg/0.5mL Pre-Filled Syringe $1447.0000
Effective date : October 18, 2010
02244016 Remicade 100mg/10mL Injection $940.0000
09852956 Remicade 100mg/10mL Injection (Compounded) $940.0000
Effective date : September 30, 2010
02331675 Cimzia 200mg/mL Pre-Filled Syringe $664.5100
Effective date : September 9, 2010
02242903 Enbrel 25mg/Vial Inj Pd-Vial Pk $184.4525
02250519 Zavesca 100mg Cap $108.5479
Effective date : March 2, 2010
02241093 Temodal 5mg Cap $7.4174
02241094 Temodal 20mg Cap $29.6694
02241095 Temodal 100mg Cap $148.3468
02312794 Temodal 140mg Cap $207.6863
02312816 Temodal 180mg Cap $267.0238
02241096 Temodal 250mg Cap $370.8565
Effective date : February 10, 2010
02284642 Azilect 0.5mg Tab $7.0000
02284650 Azilect 1mg Tab $7.0000
Effective date : January 5, 2010
01981501 Botox 100U/Vial Pd Inj-100U
Vial Pk
$357.0000
Effective date : October 8, 2009
02169649 Betaseron 0.3mg/Vial Injection $110.0000
Effective date : July 22, 2009
02317699 Revlimid 15mg Cap $382.0000
02317710 Revlimid 25mg Cap $424.0000
Effective date : June 11, 2009
02284863 Myozyme 50mg/vial Lyophylized Powder $840.3100
Effective date : June 1, 2009
02241112 Avandia 2mg Tab $1.3755
02241113 Avandia 4mg Tab $2.1584
02241114 Avandia 8mg Tab $3.0866
Effective date : May 27, 2009
02296314 Elaprase 2mg/mL 3mL Vial $3,800.00
Effective Date : January 19, 2009
02304899 Revlimid 5mg Capsule $340.0000
02304902 Revlimid 10mg Capsule $361.0000
Effective Date : December 3, 2008
2274728 Enbrel 50mg/mL Inj Pref Syr $364.2800
Effective Date : November 17, 2008
02284227 Nexavar 200mg Tablet $45.0625

Until further notice, for all other products reimbursed under the EAP, pharmacists will continue to be reimbursed their acquisition cost plus the applicable markup (currently 8%).

For more information
INFOline
Tel : 1-866-532-3161
(Toll-free in Ontario only)
TTY 1-800-387-5559
Hours of operation: 8:30am - 5:00pm
Go to top of page
|  home  |  central site  |  contact us  |  site map  |  français  |

This site maintained by the government of Ontario, Canada.